These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25953446)
1. HDAC inhibitors: a new radiosensitizer for non-small-cell lung cancer. Zhu L; Wu K; Ma S; Zhang S Tumori; 2015; 101(3):257-62. PubMed ID: 25953446 [TBL] [Abstract][Full Text] [Related]
2. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells. Zhang F; Zhang T; Teng ZH; Zhang R; Wang JB; Mei QB Cancer Biol Ther; 2009 May; 8(9):823-31. PubMed ID: 19270532 [TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation. Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861 [TBL] [Abstract][Full Text] [Related]
4. FK228 sensitizes radioresistant small cell lung cancer cells to radiation. Li H; Ma L; Bian X; Lv Y; Lin W Clin Epigenetics; 2021 Feb; 13(1):41. PubMed ID: 33632300 [TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation. Cuneo KC; Fu A; Osusky K; Huamani J; Hallahan DE; Geng L Anticancer Drugs; 2007 Aug; 18(7):793-800. PubMed ID: 17581301 [TBL] [Abstract][Full Text] [Related]
6. Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors. Hashida S; Yamamoto H; Shien K; Ohtsuka T; Suzawa K; Maki Y; Furukawa M; Soh J; Asano H; Tsukuda K; Miyoshi S; Kanazawa S; Toyooka S Oncol Rep; 2015 Mar; 33(3):1499-504. PubMed ID: 25607753 [TBL] [Abstract][Full Text] [Related]
7. A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer. Wu YH; Hong CW; Wang YC; Huang WJ; Yeh YL; Wang BJ; Wang YJ; Chiu HW Cancer Lett; 2017 Aug; 400():79-88. PubMed ID: 28450160 [TBL] [Abstract][Full Text] [Related]
8. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817 [TBL] [Abstract][Full Text] [Related]
9. [Targeted therapies and radiation therapy in non-small cell lung cancer]. Rivera S; Quéro L; Wong Hee Kam S; Maylin C; Deutsch E; Hennequin C Cancer Radiother; 2011 Oct; 15(6-7):527-35. PubMed ID: 21885318 [TBL] [Abstract][Full Text] [Related]
10. The Histone Deacetylase Inhibitor Romidepsin Spares Normal Tissues While Acting as an Effective Radiosensitizer in Bladder Tumors in Vivo. Paillas S; Then CK; Kilgas S; Ruan JL; Thompson J; Elliott A; Smart S; Kiltie AE Int J Radiat Oncol Biol Phys; 2020 May; 107(1):212-221. PubMed ID: 31987970 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition. Blattmann C; Oertel S; Ehemann V; Thiemann M; Huber PE; Bischof M; Witt O; Deubzer HE; Kulozik AE; Debus J; Weber KJ Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):237-45. PubMed ID: 20646843 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of radiation-induced DNA damage and inhibition of its repair by a novel camptothecin analog. Huang G; Wang H; Yang LX Anticancer Res; 2010 Mar; 30(3):937-44. PubMed ID: 20393017 [TBL] [Abstract][Full Text] [Related]
13. Radiosensitization effect of quinoline-indole-schiff base derivative 10E on non-small cell lung cancer cells in vitro and in tumor xenografts. Liu H; Wang Q; Lan W; Liu D; Huang J; Yao J Invest New Drugs; 2024 Aug; 42(4):405-417. PubMed ID: 38880855 [TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach. Li QQ; Hao JJ; Zhang Z; Hsu I; Liu Y; Tao Z; Lewi K; Metwalli AR; Agarwal PK Int J Oncol; 2016 Jun; 48(6):2591-607. PubMed ID: 27082124 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors. Wang EC; Min Y; Palm RC; Fiordalisi JJ; Wagner KT; Hyder N; Cox AD; Caster JM; Tian X; Wang AZ Biomaterials; 2015 May; 51():208-215. PubMed ID: 25771011 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. Zhang Y; Jung M; Dritschilo A; Jung M Radiat Res; 2004 Jun; 161(6):667-74. PubMed ID: 15161353 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells. Moertl S; Payer S; Kell R; Winkler K; Anastasov N; Atkinson MJ Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269745 [TBL] [Abstract][Full Text] [Related]
18. AT-101, a pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer. Moretti L; Li B; Kim KW; Chen H; Lu B J Thorac Oncol; 2010 May; 5(5):680-7. PubMed ID: 20354451 [TBL] [Abstract][Full Text] [Related]
19. Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. Chang TH; Szabo E Clin Cancer Res; 2002 Apr; 8(4):1206-12. PubMed ID: 11948134 [TBL] [Abstract][Full Text] [Related]